{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:148123",
      "entity_text" : "docetaxel",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P10415",
      "entity_text" : "Bcl-2",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "gene_or_gene_product"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "Evidence has shown that an elevated Bcl-2 level could contribute to the docetaxel involved chemotherapy efficacy in breast cancer, indicating that Bcl-2 expression may be regarded as a predictive biomarker for the sensitivity to this chemotherapy [XREF_BIBR].",
  "reading_complete" : "2020-08-04T12:12:03Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T12:09:10Z",
  "trigger" : "contribute",
  "evidence" : [ "Bcl-2 level could contribute to the docetaxel" ],
  "pmc_id" : "4630958",
  "score" : 0
}